SALT LAKE CITY, April 02, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in personalized medicine, today announced that its Myriad Women's Health business unit will ...
PhasED-Seq ctDNA detection enables accurate and predictive treatment response monitoring and clinical prognosis in patients with B-cell lymphoma. AURORA, Colo., Nov. 29, 2022 /PRNewswire/ -- Foresight ...
The word foresight has a mystical sound akin to fortune telling. Yet, the business reality of this growing discipline is much more practical, according to The Estée Lauder Companies’ Kalindi Mehta, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results